Phenylarsine oxide, 97%, Thermo Scientific Chemicals
Phenylarsine oxide, 97%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Phenylarsine oxide, 97%, Thermo Scientific Chemicals

Have Questions?
變更視圖buttonViewtableView
Quantity:
5 g
1 g
25 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
產品號碼 A14674.06
亦稱為 A14674-06
價格 (TWD)/ Each
-
申請報價
Quantity:
5 g
Request bulk or custom format
化學識別
CAS637-03-6
IUPAC Namearsorosobenzene
Molecular FormulaC6H5AsO
InChI KeyBQVCCPGCDUSGOE-UHFFFAOYSA-N
SMILESO=[As]C1=CC=CC=C1
檢視更多
規格Specification Sheet規格表
FormPowder
Assay from Supplier's CofA≥96.0%
Phenylarsine oxide is used as a poultry coccidiostat in veterinary medicine. It is also used in a membrane-permeable protein tyrosine phosphatase inhibitor.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Phenylarsine oxide is used as a poultry coccidiostat in veterinary medicine. It is also used in a membrane-permeable protein tyrosine phosphatase inhibitor.

Solubility
Soluble in dimethyl sulfoxide, chloroform, benzene, ether, ethanol, 50:50 dimethyl sulfoxide:1 M hydrochloric acid (3.0 mg/ml) and toluene. Insoluble in water.

Notes
Incompatible with strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Carlin, K. P.; Wu, G.; Patel, A.; Crumley, G.; Ilyin, V. I. Phenylarsine oxide as a redox modulator of transient receptor potential vanilloid type 1 channel function. J. Neurosci. Res. 2015, 93 (2), 309-320.
  2. Owen, T. S.; Xie, X. J.; Laraway, B.; Ngoje, G.; Wang, C.; Callahan, B. P. Active Site Targeting of Hedgehog Precursor Protein with Phenylarsine Oxide. ChemBioChem 2015, 16 (1), 55-58.